Abstract
Ciprofloxacin is one of the main drugs to treat bacterial infections. Bacterial infections can lead to high morbidity, mortality, and costs of treatment in the world. In this study, an analysis was conducted using the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database on the adverse events of ciprofloxacin. The aim of this study was to explore unknown associations among the adverse events of ciprofloxacin, patient demographics and adverse event outcomes. A search of FDA AERS reports was performed and some statistics was highlighted. The most frequent adverse events and event outcomes of ciprofloxacin were listed, age and gender specific distribution of adverse events are reported, then the apriori algorithm was applied to the dataset to obtain some association rules and objective measures were used to select interesting ones. Furthermore, the results were compared against classical data mining algorithms and discussed. The search resulted in 6 531 reports. The reports included within the dataset consist of 3 585 (55.8%) female and 2 884 (44.1%) male patients. The mean age of patients is 54.59 years. Preschool child, middle aged and aged groups have most adverse events reports in all groups. P...Continue Reading
References
Nov 1, 2006·Journal of Long-term Effects of Medical Implants·S Lori BrownHari Cheryl Sachs
Mar 6, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Manfred HaubenMuhammad Younus
Feb 4, 2009·Drug Discovery Today·M Hauben, A Bate
Nov 10, 2010·BMC Bioinformatics·Rave HarpazCarol Friedman
Jan 11, 2011·Lancet·Mark Walport, Paul Brest
May 17, 2011·Lancet·Geoffrey BoultonMark Walport
Sep 24, 2011·Therapeutics and Clinical Risk Management·Ayad K Ali
Jun 13, 2012·Biological & Pharmaceutical Bulletin·Kaori KadoyamaYasushi Okuno
Jun 30, 2012·International Journal of Medical Sciences·Takao TamuraYasushi Okuno
Jul 21, 2012·PloS One·Chao WangJia He
Aug 9, 2012·Acta Cardiologica·Bernhard Haring, Wolfgang Bauer
Jan 17, 2013·Journal of Medical Systems·Dong Gyu LeeKeun Ho Ryu
Mar 9, 2013·International Journal of Medical Sciences·Sharon L HoogSherie A Dowsett
Mar 27, 2013·Pediatrics·UNKNOWN American Academy of Pediatrics Council on Clinical Information Technology Executive Committee, 2011–2012
Apr 11, 2013·Clinical Pharmacology and Therapeutics·R HarpazN H Shah
Jun 26, 2013·International Journal of Medical Sciences·Toshiyuki SakaedaYasushi Okuno
Jul 23, 2013·International Journal of Clinical Pharmacy·Brady S MoffettJeffrey J Kim
Jan 1, 2014·Health Information Science and Systems·Wullianallur Raghupathi, Viju Raghupathi
Citations
Mar 18, 2017·Journal of Clinical Psychopharmacology·Sahil Munjal, Yvette Smolin
Jan 31, 2017·Pharmacology & Therapeutics·Daniel F CarrMunir Pirmohamed
Jul 22, 2017·PloS One·Shiori HasegawaMitsuhiro Nakamura
May 18, 2018·SAGE Open Medicine·Misa NaganumaMitsuhiro Nakamura
Feb 28, 2019·International Journal of Clinical Practice·Long MengShusen Sun
Oct 9, 2019·PloS One·Mizuki TanakaMitsuhiro Nakamura
Sep 2, 2020·Pharmacoepidemiology and Drug Safety·Shiori HasegawaMitsuhiro Nakamura
Jun 13, 2020·SAGE Open Medicine·Kiyoka MatsumotoMitsuhiro Nakamura
Jul 22, 2017·Journal of Pharmaceutical Health Care and Sciences·Haruna HatahiraMitsuhiro Nakamura
Dec 24, 2018·Journal of Pharmaceutical Health Care and Sciences·Haruna HatahiraMitsuhiro Nakamura
Jul 16, 2021·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Mohamed Kadry TaherDaniel Krewski
Oct 14, 2021·Expert Opinion on Drug Safety·Mohamed Kadry TaherDaniel Krewski